SCHEMBL6724575

SCHEMBL6724575

O=C(c1cc(I)c(O)c(I)c1)c1ccccc1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.56
▸ ALDH1A1 P00352 4/20 0.56
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ CYP2C9 P11712 3/20 0.56
▸ LMNA P02545 2/20 0.56
▸ TTR P02766 2/20 0.56
▸ THRB P10828 2/20 0.56
▸ HPGD P15428 2/20 0.56
▸ RECQL P46063 2/20 0.56
▸ BLM P54132 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ GMNN O75496 1/20 0.56
▸ TP53 P04637 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ TSHR P16473 1/20 0.56
▸ NFKB1 P19838 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ GFER P55789 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2786142 0.83 ALDH1A1 (0.50) MAPTALDH1A1MEN1KMT2ACYP2C9
SCHEMBL16326127 0.80 ALDH1A1 (0.61) MAPTALDH1A1MEN1KMT2ACYP2C9
SCHEMBL29405270 0.79 ALOX5 (0.55) MAPTALDH1A1MEN1KMT2ACYP2C9
SCHEMBL8075421 0.79 GABRA1 (0.64) MAPTALDH1A1MEN1KMT2ACYP2C9
SCHEMBL10759830 0.77 CES2 (0.62) MAPTALDH1A1MEN1KMT2ACYP2C9
SCHEMBL12856551 0.77 TDP1 (0.57) MAPTALDH1A1MEN1KMT2ACYP2C9
SCHEMBL6721207 0.76 GABRA1 (0.59) MAPTALDH1A1MEN1KMT2ACYP2C9
SCHEMBL9240475 0.76 TDP1 (0.56) MAPTALDH1A1MEN1KMT2ACYP2C9
SCHEMBL2705078 0.76 KDM4E (0.46) MAPTALDH1A1MEN1KMT2ACYP2C9
SCHEMBL28215241 0.76 KDM4E (0.46) MAPTALDH1A1MEN1KMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6677473-B1 TREATMENT, PREVENTION OR AMELIORATION OF ONE OR MORE SYMPTOMS OF THROMBOTIC DISORDERS, UNSTABLE ANGINA OR CANCER CORVAS INTERNATIONAL INC 2004-01-13 — — US disclosed
WO-2001036351-A2 PLASMINOGEN ACTIVATOR INHIBITOR ANTAGONISTS RELATED APPLICATIONS CORVAS INTERNATIONAL, INC. (US) 2001-05-25 — — WO disclosed
Send feedback